Mizuho Downgrades Pediatrix Medical Group to Underperform, Maintains Price Target to $28
Benzinga Newsdesk 3 hours ago
Analyst RatingsNewsDowngradesPrice Target
Mizuho analyst Ann Hynes downgrades Pediatrix Medical Group (NYSE:MD) from Neutral to Underperform and maintains the price target from $28 to $28.
Mizuho analyst Ann Hynes downgrades Pediatrix Medical Group (NYSE:MD) from Neutral to Underperform and maintains the price target from $28 to $28.